Replies to post #121581 on Biotech Values

[investorgold2002]

Dew - so no new product launch until 2016??? other than copaxone

realistically, when can Enbrel be filed under FOB pathway by MNTA and assume say 14 month(out of the blue num#) review time ?


when can Enbrel be filed under FOB pathway by MERCK and assume say 14 month(out of the blue num#) review time ?


Also your thoughts on Merck Enbrel and how this may apply to MNTA's Enbrel ? It seems like overvalued (of course it could be contingent on meeting sales milestone) considering that product may not get substitutability ?